USX:CBMX - CombiMatrix Corp (USD 6.25) CombiMatrix Corp
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist
   


Yahoo Finance
Note: This stock seems to be inactive

USD 6.25    -0.205 (-3.18%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

14 Nov 2017


Overview

14 Nov 2017

Day Change: -0.205 (-3.18%)

52 Wk Range: 2.35 - 8.2

Day's Range: 6.105 - 6.6

Last Volume: 51,819

Current Yield: 0%

Projected Yield: 0%

Open: USD 6.55

2 Aug 2018

Metric CBMX S.Median
Beta NA 0.78
VaR NA 21.09
E.Shortfall NA 29.34
Liquidity NA 92.34K

Fundamental

14 Nov 2017

PE: -8.893

Market Cap: 18.3M

Price Over Book: 3.467

Price Over Sales: 1.17

Return On Assets: -26.6%

Return On Equity: -39%

Price Over NAV: [Friends Only]

General

CEO: Mark D. McDonough

Headquarters: Irvine

Employees: 55

Sector: Health Technology

Industry: Medical Specialties

Useful Links
Homepage

Description

CombiMatrix Corporation provides clinical molecular diagnostic laboratory services in the United States. The company focuses on pre-implantation genetic screening, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. It provides molecular diagnostic services primarily in the areas of reproductive health for the diagnosis of developmental disorders associated with intellectual disability, congenital anomalies, dysmorphic features, and autism spectrum disorders. The company's testing focuses on advanced technologies, including single nucleotide polymorphism, chromosomal microarray analysis, sequencing, fluorescent in situ hybridization, and high resolution karyotyping. It serves commercial insurance companies, healthcare institutions, government payors, and individuals. CombiMatrix Corporation was founded in 1995 and is headquartered in Irvine, California.